1329 Results

People

  1. Motzer
    Motzer
  2. Saltz
    Saltz
  3. Kelsen
    Kelsen
  4. Bajorin
    Bajorin
  5. Hudis
    Hudis
  6. Bosl
    Bosl
  7. Scher
    Scher
  8. Kemeny
    Kemeny
  9. Kris
    Kris
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (792)
  2. Solid Tumor Oncology Division (596)
  3. Survivorship Research (274)
  4. Surgery (268)
  5. Center for Hematologic Malignancies (227)
  6. Hematologic Malignancies, Division of (218)
  7. Gastrointestinal Oncology Service (176)
  8. Genitourinary Oncology Service (141)
  9. Center for Pancreatic Cancer Research (127)
  10. Epidemiology and Biostatistics (116)
  1. "cancer combination chemotherapy"
Formats
  1. Journal Article (1259)
  2. Review (30)
  3. Conference Paper (21)
  4. Editorial (9)
  5. Research Letter (6)
  6. Guidelines (3)
  7. Correspondence (1)
Groups
  1. Department of Medicine (792)
  2. Solid Tumor Oncology Division (596)
  3. Survivorship Research (274)
  4. Surgery (268)
  5. Center for Hematologic Malignancies (227)
  6. Hematologic Malignancies, Division of (218)

More Groups

People
  1. Robert Motzer (54)
  2. Leonard Saltz (51)
  3. George Bosl (49)
  4. David Kelsen (47)
  5. Clifford Hudis (45)
  6. Dean Bajorin (45)

More People

Years
  1. 2024 (10)
  2. 2023 (38)
  3. 2022 (25)
  4. 2021 (19)
  5. 2020 (35)
  6. 2019 (26)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer (78)
  3. Gynecologic Oncology (44)
  4. Seminars in Oncology (34)
  5. Blood (32)
  6. Journal of the National Comprehensive Cancer Network (32)

More Publications

Publishers
  1. Elsevier Inc. (237)
  2. American Society of Clinical Oncology (162)
  3. Springer (99)
  4. Wiley Blackwell (96)
  5. Lippincott Williams & Wilkins (67)
  6. Elsevier Science, Inc. (63)

More Publishers

Results (1329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients
    Journal Article

    Lee, V.; Parkinson, R.; Zahurak, M.; Cope, L.; Cercek, A.; Verheul, H.; Gootjes, E.; Lenz, H. J.; Iqbal, S.; Jones, P.; more...
    International Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics
    Journal Article

    El Homsi, M.; Bane, O.; Fauveau, V.; Hectors, S.; Vietti Violi, N.; Sylla, P.; Ko, H. B.; Cuevas, J.; Carbonell, G.; Nehlsen, A.; more...
    Abdominal Radiology (2024)

    Fulltext@MSK | Save
  • Analysis of East Asia subgroup in Study 309/KEYNOTE-775: Lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer
    Journal Article

    Yonemori, K.; Fujiwara, K.; Hasegawa, K.; Yunokawa, M.; Ushijima, K.; Suzuki, S.; Shikama, A.; Minobe, S.; Usami, T.; Kim, J. W.; more...
    Journal of Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Trials and tribulations in rare cancer clinical research
    Editorial

    Maki, R. G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Anal adenocarcinoma treated in the era of total neoadjuvant therapy and nonoperative management
    Journal Article

    Feferman, Y.; Rosen, R. Y.; Gebran, S.; Yuval, J. B.; Kerioui, M.; Gönen, M.; Wei, I. H.; Widmar, M.; Nash, G. M.; Weiser, M. R.; more...
    Diseases of the Colon and Rectum (2024)

    Fulltext@MSK | Save
  • Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Research Letter

    Badar, T.; Nanaa, A.; Atallah, E.; Shallis, R. M.; Guilherme, S. D. C. C.; Goldberg, A. D.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; DuVall, A. S.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1-SSX3 gene fusion
    Journal Article

    Fumagalli, C.; Orellana, R.; Ferré, M.; Gonzalez, A.; Catasús, L.; Vázquez, T.; Sebio, A.; López-Pousa, A.; Llauger, J.; Peiró, A.; more...
    Genes Chromosomes and Cancer (2024)

    Fulltext@MSK | Save
  • Progression-free survival of daratumumab versus bortezomib triplet combination with lenalidomide and dexamethasone in transplant ineligible patients with newly diagnosed multiple myeloma: TAURUS chart review study
    Journal Article

    Gordan, L. N.; Tan, C. R.; Vescio, R.; Ye, J. C.; Schinke, C.; Medhekar, R.; Fu, A. Z.; Lafeuille, M. H.; Thompson-Leduc, P.; Khare, V.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • POSing the question: MARIPOSA-2, do the ends justify the means?
    Editorial

    Chen, M. F.; Piotrowska, Z.; Yu, H. A.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer
    Journal Article

    Boerner, T.; Lam, C.; Basaran, D.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Long Roche, K.; Zivanovic, O.; Abu-Rustum, N. R.; Gardner, G. J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save